The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease.
about
Erectile dysfunction and central obesity: an Italian perspectiveCardiovascular safety of phosphodiesterase inhibitors for treating erectile dysfunction in elderly menClinical use of alprostadil topical cream in patients with erectile dysfunction: a reviewThe Wonders of Phosphodiesterase-5 Inhibitors: A Majestic HistoryHypogonadism and erectile dysfunction as harbingers of systemic diseaseCan lifestyle modification affect men's erectile function?Hyperhomocysteinaemia in rats is associated with erectile dysfunction by impairing endothelial nitric oxide synthase activity.Pharmacogenetics of erectile dysfunction: navigating into uncharted watersThe SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with Erectile Dysfunction Treated with Vardenafil.Cardiovascular rehabilitation, ballroom dancing and sexual dysfunctionManagement of erectile dysfunction in hypertension: Tips and tricks.Men's Health Index: a pragmatic approach to stratifying and optimizing men's healthDevelopment of UK recommendations on treatment for post-surgical erectile dysfunction.Sexual counseling and cardiovascular disease: practical approaches.Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis.Current Diagnosis and Management of Erectile DysfunctionSurvivorship: sexual dysfunction (male), version 1.2013The Association of Erectile Dysfunction and Cardiovascular Disease: A Systematic Critical Review.Men's Health: What Should We Know?Commentary on "Late-onset hypogonadism - beyond testosterone".Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial.Erectile dysfunction, vascular risk, and cognitive performance in late middle age.Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis.Erectile dysfunction as a predictor of asymptomatic coronary artery disease in elderly men with type 2 diabetesThe CopenHeartSF trial--comprehensive sexual rehabilitation programme for male patients with implantable cardioverter defibrillator or ischaemic heart disease and impaired sexual function: protocol of a randomised clinical trial.Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality.Do residents in cardiology need more training to make them talk about sex?Diabetes and sexual dysfunction: current perspectives.Attitudes and Performance of Cardiologists Toward Sexual Issues in Cardiovascular Patients.Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies.Sexual health of male cardiac patients - present status and expectations of patients with coronary heart disease.Testosterone deficiency, cardiac health, and older men.Erectile dysfunction in the cardiovascular patient.How can heart failure patients and their partners be counseled on sexual activity?An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors.The evaluation and treatment of prostate-related LUTS in the primary care setting: the next STEP.Pharmacologic therapy for erectile dysfunction and its interaction with the cardiovascular system.Should men with mild erectile dysfunction be closely evaluated for cardiovascular diseases in the Korean population?Treatment strategies for diabetic patients suffering from erectile dysfunction: an update.
P2860
Q22241096-16F4411B-0360-49EF-A0F2-2629E126B46EQ24194249-23D4FCFC-F388-47D8-B5F6-FB8F4A104B6EQ26740510-DA5FAFE1-68A5-4DF7-8B3F-0F4E284FA77DQ26741387-5F9B4DF3-4720-4401-BA7F-1C0EC615FDC8Q26747672-71DBAF93-4AD8-4C08-999D-36DCBE656394Q26747675-3347DBB4-0E78-457F-BDDE-18C02DA09ECFQ27312470-43D249A0-9CA8-4B5D-8AEA-F7C34F9F6605Q28249515-E6B11BC2-A4D2-4F38-98CE-8F63F0C342FEQ33737324-219C0858-F2D6-4FFC-AB0E-9FB5A66C0EEEQ33933321-687D67DC-00D1-49B7-88CA-36592AD745FDQ34251875-E9C35CB2-27B4-4EC0-B3C3-F52E666F58D9Q34506843-EE89901C-52B2-4FC2-BE4C-A2D00484314CQ34788432-94270DC3-AFB5-4095-A4D7-C03FE1D47453Q34927898-05AD528F-071A-4DF8-8DD5-EE20019D3DA8Q35328376-E6D34EB6-C805-4E0A-A334-BFD3BA4CDDB1Q35384480-8EAC3A94-87F6-47E5-88E5-B5CA46137567Q35735012-A0F21004-F979-41DC-AF2A-8DEDC3E1FA93Q35914768-2A1D1150-1902-4830-B24F-A97CA64760DBQ35998584-E40B0570-D8DD-410A-B2FA-1455BDCB295DQ36293089-23F999A7-B6E6-4357-8FF1-7BE8069A86FFQ36781932-7F3F98C2-4122-4F9B-B66F-0720202F9D46Q36851296-7D9B7EA2-D661-42F9-A10B-246C12DDD0C7Q36861695-55CA3EA0-F68C-42A5-847A-C4E8E21E9210Q37108885-44611ABF-F4D8-46C8-A226-C28383E141EFQ37180936-ABE1BC32-C540-45B7-8F58-AF2FB0E56BEBQ37352860-D813BCD1-6438-4421-B414-E998F52E7D6CQ37398972-7A484374-02CD-49EA-8942-CE9BB6728658Q37597784-EE2820EB-92EC-43FF-9B63-7674999EE904Q37630425-A99AA380-4FD6-4F15-9DD5-A2EA53131016Q37636063-E7A598D8-6C86-4AF9-92DA-8C6C3FCCCF8DQ37647225-A04579A7-00FF-401E-BAAF-D5E1B2A5EA42Q37675579-552FFD9A-7713-4922-B8BA-4AD375681A2EQ37724941-2BE8018D-9E0A-44C5-9829-6B24256DF61AQ38101543-BA55DAA6-47F7-4D57-8323-BF6607433D21Q38105997-B87A139A-36FB-4C36-A1DC-2CB80F12D60CQ38107001-F3C8B267-A614-4DCE-B547-6F05273A369CQ38136528-31C4FCCB-4731-4151-8339-999D9A815B87Q38166600-0147BF18-AB75-4BB0-A8A4-635FB8780CD1Q38176428-17724E0B-57E9-46A3-AD1F-CB3E5318B094Q38224353-D7F3EC9B-A51D-4211-B0E0-1047B1E32C42
P2860
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The Princeton III Consensus re ...... on and cardiovascular disease.
@ast
The Princeton III Consensus re ...... on and cardiovascular disease.
@en
type
label
The Princeton III Consensus re ...... on and cardiovascular disease.
@ast
The Princeton III Consensus re ...... on and cardiovascular disease.
@en
prefLabel
The Princeton III Consensus re ...... on and cardiovascular disease.
@ast
The Princeton III Consensus re ...... on and cardiovascular disease.
@en
P2093
P2860
P1476
The Princeton III Consensus re ...... on and cardiovascular disease.
@en
P2093
Ajay Nehra
Allen D Seftel
Andre T Guay
Arthur L Burnett
Charalambos Vlachopoulos
Culley C Carson
Frederick C W Wu
Geoff Hackett
Glenn R Cunningham
Graham Jackson
P2860
P304
P356
10.1016/J.MAYOCP.2012.06.015
P407
P577
2012-08-01T00:00:00Z